Williams Jones & Associates’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$149M Sell
541,523
-6,600
-1% -$1.63M 3.09% 3
2019
Q1
$123M Buy
548,123
+61,247
+13% +$12.6M 2.71% 4
2018
Q4
$90.6M Buy
486,876
+24,266
+5% +$4.97M 2.46% 7
2018
Q3
$115M Sell
462,610
-54,037
-10% -$13.1M 2.33% 4
2018
Q2
$113M Sell
516,647
-8,918
-2% -$1.84M 2.48% 4
2018
Q1
$101M Sell
525,565
-11,569
-2% -$2.14M 2.33% 7
2017
Q4
$84M Buy
537,134
+1,827
+0.3% +$288K 1.91% 13
2017
Q3
$83.2M Sell
535,307
-6,155
-1% -$973K 2.05% 11
2017
Q2
$87.4M Sell
541,462
-47,370
-8% -$7.69M 2.21% 9
2017
Q1
$91M Sell
588,832
-50,910
-8% -$7.02M 2.38% 6
2016
Q4
$75M Sell
639,742
-13,276
-2% -$1.51M 2.14% 8
2016
Q3
$73.6M Sell
653,018
-4,513
-0.7% -$476K 2.15% 9
2016
Q2
$61.1M Buy
+657,531
New +$56.5M 1.88% 14

Other funds holding IDXX

Williams Jones & Associates's IDXX Position: Q2 2019 in Review

Williams Jones & Associates reduced its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2019, selling an estimated $1.63M and leaving 541,523 shares worth $149M. The position accounts for 3.09% of the portfolio, ranked #3.

Williams Jones & Associates first reported a position in IDXX in Q2 2016 and has held it in 13 quarters since. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Williams Jones & Associates held 541,523 shares of Idexx Laboratories worth $149M as of Q2 2019.
  • Williams Jones & Associates sold 6,600 Idexx Laboratories shares in Q2 2019, an estimated $1.63M.
  • Idexx Laboratories made up 3.09% of Williams Jones & Associates's portfolio in Q2 2019, its #3 holding.
  • Williams Jones & Associates first reported a position in Idexx Laboratories in Q2 2016 and has held it in 13 quarters since.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.